Igor Feoktistov Selected Research

Igor Feoktistov Research Topics

Disease

7	Myocardial Infarction 12/2022 - 07/2011
6	Neoplasms (Cancer) 11/2023 - 03/2003
4	Fibrosis (Cirrhosis) 12/2022 - 01/2009
4	Asthma (Bronchial Asthma) 09/2015 - 01/2004
3	Infarction (Infarctions) 11/2016 - 09/2013
3	Lewis Lung Carcinoma 01/2014 - 09/2008
3	Inflammation (Inflammations) 01/2011 - 06/2004
2	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 09/2008
2	2 Gingival Fibromatosis 05/2017 - 10/2014
2	Heart Failure 11/2016 - 10/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2015 - 01/2004
2	Cicatrix (Scar) 09/2014 - 01/2009
2	Ischemia 02/2008 - 03/2003
2	Hypoxia (Hypoxemia) 02/2007 - 11/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023
1	Melanoma (Melanoma, Malignant) 11/2023
1	Triple Negative Breast Neoplasms 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2017
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Pre-Eclampsia (Preeclampsia) 01/2014
1	Lung Diseases (Lung Disease) 05/2010
1	Pneumonia (Pneumonitis) 05/2010
1	Hyperplasia 05/2010
1	Airway Remodeling 05/2010
1	Hypertrophy 05/2010
1	Wounds and Injuries (Trauma) 01/2009
1	Leukemia 06/2004
1	Mental Disorders (Mental Disorder) 06/2004

Drug/Important Bio-Agent (IBA)

15	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 06/2004
14	Adenosine (Adenocard)FDA LinkGeneric 11/2023 - 03/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 11/2004
3	Adenosine DeaminaseIBA 11/2023 - 02/2007
3	CollagenIBA 01/2020 - 09/2014
2	ErbB Receptors (EGF Receptor)IBA 11/2023 - 05/2017
2	NucleotidesIBA 12/2022 - 01/2016
2	Neuregulin-1 (Neuregulin 1)IBA 05/2017 - 10/2014
2	Protein Isoforms (Isoforms)IBA 05/2017 - 10/2014
2	LigandsIBA 11/2016 - 10/2015
2	CytokinesIBA 09/2015 - 06/2004
2	Proteins (Proteins, Gene)FDA Link 09/2014 - 05/2010
2	Adenosine A2B ReceptorIBA 09/2014 - 09/2013
2	AntigensIBA 09/2013 - 06/2012
2	Messenger RNA (mRNA)IBA 05/2010 - 11/2004
2	Interleukin-4 (Interleukin 4)IBA 05/2010 - 06/2004
2	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 02/2007 - 06/2004
1	Programmed Cell Death 1 ReceptorIBA 11/2023
1	InterferonsIBA 11/2023
1	Phosphates (Orthophosphate)IBA 11/2023
1	triphosphoric acid (triphosphate)IBA 12/2022
1	CD39 antigenIBA 12/2022
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	EnzymesIBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2017
1	CateninsIBA 11/2016
1	NucleosidesIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2014
1	Transforming Growth Factor-beta Type II ReceptorIBA 09/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2010
1	OvalbuminIBA 05/2010
1	AllergensIBA 05/2010
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2009
1	erucylphosphocholineIBA 02/2008
1	LipopolysaccharidesIBA 02/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008
1	Interleukin-8 (Interleukin 8)IBA 02/2007
1	Oxygen (Dioxygen)IBA 02/2007
1	Actins (F Actin)IBA 11/2004
1	ElementsIBA 11/2004
1	Interleukin-13IBA 06/2004
1	Immunoglobulin E (IgE)IBA 06/2004
1	Serotonin (5 Hydroxytryptamine)IBA 06/2004
1	Sildenafil Citrate (Viagra)FDA Link 06/2004
1	Phosphodiesterase InhibitorsIBA 06/2004
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2004

Therapy/Procedure

3	Therapeutics 11/2023 - 07/2011
1	Intravenous Injections 11/2016
1	Ligation 10/2015
1	Transplantation 09/2013